Mouse IL-6 FlowCytomix Simplex

Description: This Mouse Interleukin 6 FlowCytomix Simplex Kit is designed for the measurement of murine IL-6 in a bead based immunoassay analyzed on a flow cytometer.

eBioscience bead-based immunoassays follow the same principle as a sandwich immunoassay.

Basic Kits include essential core reagents and are required to successfully perform assays using combinations of Simplex Kits.

This kit contains the following bead population A10.

Interleukin-6 (IL-6) is a multi-functional cytokine that regulates immune responses, acute phase reactions and hematopoiesis and may play a central role in host defense mechanisms. IL-6 is usually not produced constitutively by normal cells, but its expression is readily induced by a variety of cytokines,lipopolysaccharide (LPS) or viral infections. IL-6 is a pleiotropic cytokine produced by a variety of cells. It acts on a wide range of tissues, exerting growth-induction, growth-inhibition, and differentiation respectively, depending on the nature of the target cells.

IL-6 is involved in:

- the induction of B-cell differentiation
- the induction of acute phase proteins in liver cells
- growth promotion of myeloma/plasmacytoma/hybridoma cells
- induction of IL-2 and IL-2 receptor expression
- proliferation and differentiation of T cells
- inhibition of cell growth of certain myeloid leukemic cell lines and induction of their differentiation to macrophages
- enhancement of IL-3-induced multipotential colony cell formation in hematopoietic stem cells and induction of maturation of megakaryocytes as a thrombopoietic factor
- induction of mesangial cell growth
- induction of neural differentiation of PC 12 cells
- induction of keratinocyte growth

The abnormal production of IL-6 was first suggested to be related to polyclonal B-cell activation with autoantibody production in patients with cardiac myxoma. Since then, IL-6 has been suggested to be involved in the pathogenesis of a variety of diseases. Measurement of IL-6 levels in serum and other body fluids thus provides more detailed insights into various pathological situations.

Citations: Wirtz,Stefan; Tubbe,Ingrid; Galle,Peter R.; Schild,Hans J.; Birkenbach,Mark; Blumberg,Richard S.; Neurath,Markus F.. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. Journal of Experimental Medicine 2006;203:1875-1881. (Link)

Romano M,D'Souza S,Adnet PY,Laali R,Jurion F,Palfliet K,Huygen K.. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.. Vaccine 2006;24:4640-4643. (Link)

O'Connor,Richard A.; Prendergast,Catriona T.; Sabatos,Catherine A.; Lau,Clement W.Z.; Leech,Melanie D.; Wraith,David C.; Anderton,Stephen M.. Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 2008;181:3750-3754. (Link)

Raveney,Ben J.E.; Richards,Claire; Aknin,Marie Laure; Copland,David A.; Burton,Bronwen R.; Kerr,Emma; Nicholson,Lindsay B.; Williams,Neil A.; Dick,Andrew D.. The B Subunit of Escherichia coli Heat-Labile Enterotoxin Inhibits Th1 but Not Th17 Cell Responses in Established Experimental Autoimmune Uveoretinitis. Investigative Ophthalmology & Visual Science 2008;49:4008-4017. (Link)

Cuesta,Angel M.; Suarez,Eduardo; Larsen,Martin; Jensen,Kim Bak; Sanz,Laura; Compte,Marta; Kristensen,Peter; varez-Vallina,Luis. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology 2006;117:502-506. (Link)

Brignole,C.; Marimpietri,D.; Pastorino,F.; Di,Paolo D.; Pagnan,G.; Loi,M.; Piccardi,F.; Cilli,M.; Tradori-Cappai,A.; Arrigoni,G.; Pistoia,V.; Ponzoni,M.. Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides. J Control Release 2009;(Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

Leppkes,Moritz; Becker,Christoph; Ivanov,Ivaylo I.; Hirth,Sebastian; Wirtz,Stefan; Neufert,Clemens; Pouly,Sandrine; Murphy,Andrew J.; Valenzuela,David M.; Yancopoulos,George D.; Becher,Burkhard; Littman,Dan R.; Neurath,Markus F.. RORgamma expressing Th17 cells drive chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136:257-267. (Link)

Thomas,Ian J.; Petrich de Marquesini,Liliana G.; Ravanan,Rommel; Smith,Richard M.; Guerder,Sylvie; Flavell,Richard A.; Wraith,David C.; Wen,Li; Wong,F.Susan. CD86 Has Sustained Costimulatory Effects on CD8 T Cells. The Journal of Immunology 2007;179:5936-5946. (Link)

Ataman-™nal,Y.; Munier,S.; Ganee,A.; Terrat,C.; Durand,P.Y.; Battail,N.; Martinon,F.; Le,Grand R.; Charles,M.H.; Delair,T.; Verrier,B.. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Release 2006;112:175-185. (Link)

Ganta,Roman R.; Cheng,Chuanmin; Miller,Elizabeth C.; McGuire,Bridget L.; Peddireddi,Lalitha; Sirigireddy,Kamesh R.; Chapes,Stephen K.. Differential Clearance and Immune Responses to Tick Cell vs. Macrophage Culture-Derived Ehrlichia chaffeensis in Mice. Infection and Immunity 2006;75:135-145. (Link)

Timmers,Leo; van Keulen,J.Karlijn; Hoefer,Imo E.; Meijs,Matthijs F.L.; van Middelaar,Ben; den Ouden,Krista; van Echteld,Cees J.A.; Pasterkamp,Gerard; de Kleijn,Dominique P.V.. Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction. Circulation Research 2009;104:699-706. (Link)

Timmers L,Sluijter JP,van Keulen JK,Hoefer IE,Nederhoff MG,Goumans MJ,Doevendans PA,van Echteld CJ,Joles JA,Quax PH,Piek JJ,Pasterkamp G,de Kleijn DP.. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102:257-264. (Link)

Liu,Qi; Cheng,Lily I.; Yi,Liang; Zhu,Nannan; Wood,Adam; Changpriroa,Cattlena May; Ward,Jerrold M.; Jackson,Sharon H.. p47phox Deficiency Induces Macrophage Dysfunction Resulting in Progressive Crystalline Macrophage Pneumonia. American Journal of Pathology 2009;174:153-163. (Link)

Loser,Karin; Apelt,Jenny; Voskort,Maik; Mohaupt,Mariette; Balkow,Sandra; Schwarz,Thomas; Grabbe,Stephan; Beissert,Stefan. IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice. The Journal of Immunology 2007;179:365-371. (Link)

Hildner,K.M.; Schirmacher,P.; Atreya,I.; Dittmayer,M.; Bartsch,B.; Galle,P.R.; Wirtz,S.; Neurath,M.F.. Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J Immunol 2007;178:3427-3436. (Link)

Fletcher,Julie M.; Jordan,Margaret A.; Snelgrove,Sarah L.; Slattery,Robyn M.; Dufour,Francois D.; Kyparissoudis,Konstantinos; Besra,Gurdyal S.; Godfrey,Dale I.; Baxter,Alan G.. Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4. The Journal of Immunology 2008;181:3400-3412. (Link)

Pozdzik,A.A.; Salmon,I.J.; Husson,C.P.; Decaestecker,C.; Rogier,E.; Bourgeade,M.F.; schodt-Lanckman,M.M.; Vanherweghem,J.L.; Nortier,J.L.. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol.Dial.Transplant 2008;23:2480-2491. (Link)

Presser,Katrin; Schwinge,Dorothee; Wegmann,Michael; Huber,Samuel; Schmitt,Steffen; Quaas,Alexander; Maxeiner,Joachim H.; Finotto,Susetta; Lohse,Ansgar W.; Blessing,Manfred; Schramm,Christoph. Coexpression of TGF-{beta}1 and IL-10 Enables Regulatory T Cells to Completely Suppress Airway Hyperreactivity. The Journal of Immunology 2008;181:7751-7758. (Link)

Mrabet-Dahbi,S.; Metz,M.; Dudeck,A.; Zuberbier,T.; Maurer,M.. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp.Dermatol. 2009;18:437-444. (Link)

Claudio,Estefania; Sonder,Soren Ulrik; Saret,Sun; Carvalho,Gabrielle; Ramalingam,Thirumalai R.; Wynn,Thomas A.; Chariot,Alain; Garcia-Perganeda,Antonio; Leonardi,Antonio; Paun,Andrea; Chen,Amy; Ren,Nina Y.; Wang,Hongshan; Siebenlist,Ulrich. The Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation. The Journal of Immunology 2009;182:1617-1630. (Link)

Weigmann,Benno; Lehr,Hans A.; Yancopoulos,George; Valenzuela,David; Murphy,Andrew; Stevens,Sean; Schmidt,Jan; Galle,Peter R.; Rose-John,Stefan; Neurath,Markus F.. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. Journal of Experimental Medicine 2008;205:2099-2110. (Link)

Fantini,M.C.; Becker,C.; Tubbe,I.; Nikolaev,A.; Lehr,H.A.; Galle,P.; Neurath,M.F.. Transforming growth factor {beta} induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006;55:671-680. (Link)

Tran,Elise H.; Azuma,Yasu Taka; Chen,Manchuan; Weston,Claire; Davis,Roger J.; Flavell,Richard A.. Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain. Proceedings of the National Academy of Sciences U.S.A. 2006;103:13451-13456. (Link)

References: Helfgott,D.C.; Tatter,S.B.; Santhanam,U.; Clarick,R.H.; Bhardwaj,N.; May,L.T.; Sehgal,P.B.. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J.Immunol. 1989;142:948-953. (Link)

Ueyama,M.; Maruyama,I.; Osame,M.; Sawada,Y.. Marked increase in plasma interleukin-6 in burn patients. J.Lab Clin.Med. 1992;120:693-698. (Link)

May,L.T.; Santhanam,U.; Tatter,S.B.; Bhardwaj,N.; Ghrayeb,J.; Sehgal,P.B.. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem.Biophys.Res.Commun. 1988;152:1144-1150. (Link)

Martinez-Maza,O.. IL6 and AIDS. Res.Immunol. 1992;143:764-769. (Link)

Santhanam,U.; Avila,C.; Romero,R.; Viguet,H.; Ida,N.; Sakurai,S.; Sehgal,P.B.. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 1991;3:155-163. (Link)

Nakajima,K.; Martinez-Maza,O.; Hirano,T.; Breen,E.C.; Nishanian,P.G.; Salazar-Gonzalez,J.F.; Fahey,J.L.; Kishimoto,T.. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J.Immunol. 1989;142:531-536. (Link)

Cayphas,S.; Van,Damme J.; Vink,A.; Simpson,R.J.; Billiau,A.; Van,Snick J.. Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection. J.Immunol. 1987;139:2965-2969. (Link)

Koj Aleksander. Regulation of the acute phase and immune responses: interleukin-6. Ann.N Y.Acad.Sci. 1989;557:1-583. (Link)

Hirano,T.; Matsuda,T.; Turner,M.; Miyasaka,N.; Buchan,G.; Tang,B.; Sato,K.; Shimizu,M.; Maini,R.; Feldmann,M.; .. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur.J.Immunol. 1988;18:1797-1801. (Link)

Sheron,N.; Bird,G.; Goka,J.; Alexander,G.; Williams,R.. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin.Exp.Immunol. 1991;84:449-453. (Link)

Zilberstein,A.; Ruggieri,R.; Korn,J.H.; Revel,M.. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986;5:2529-2537. (Link)

Helle,M.; Brakenhoff,J.P.; De Groot,E.R.; Aarden,L.A.. Interleukin 6 is involved in interleukin 1-induced activities. Eur.J.Immunol. 1988;18:957-959. (Link)

Pettersson,T.; Metsarinne,K.; Teppo,A.M.; Fyhrquist,F.. Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases. J.Intern.Med. 1992;232:439-442. (Link)

Hirano,T.; Yasukawa,K.; Harada,H.; Taga,T.; Watanabe,Y.; Matsuda,T.; Kashiwamura,S.; Nakajima,K.; Koyama,K.; Iwamatsu,A.; .. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-76. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N Y.Acad.Sci. 1989;557:353-361. (Link)

May,L.T.; Ghrayeb,J.; Santhanam,U.; Tatter,S.B.; Sthoeger,Z.; Helfgott,D.C.; Chiorazzi,N.; Grieninger,G.; Sehgal,P.B.. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J.Biol.Chem. 1988;263:7760-7766. (Link)

Hirano,T.; Taga,T.; Nakano,N.; Yasukawa,K.; Kashiwamura,S.; Shimizu,K.; Nakajima,K.; Pyun,K.H.; Kishimoto,T.. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc.Natl.Acad.Sci.U S A 1985;82:5490-5494. (Link)

Oka,Y.; Murata,A.; Nishijima,J.; Yasuda,T.; Hiraoka,N.; Ohmachi,Y.; Kitagawa,K.; Yasuda,T.; Toda,H.; Tanaka,N.; .. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992;4:298-304. (Link)

Horii,Y.; Iwano,M.; Hirata,E.; Shiiki,M.; Fujii,Y.; Dohi,K.; Ishikawa,H.. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int.Suppl 1993;39:S71-S75. (Link)

Ray,A.; Tatter,S.B.; Santhanam,U.; Helfgott,D.C.; May,L.T.; Sehgal,P.B.. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann.N.Y.Acad.Sci. 1989;557:353-361. (Link)

Hirano,T.; Akira,S.; Taga,T.; Kishimoto,T.. Biological and clinical aspects of interleukin 6. Immunol.Today 1990;11:443-449. (Link)

Elder,J.T.; Sartor,C.I.; Boman,D.K.; Benrazavi,S.; Fisher,G.J.; Pittelkow,M.R.. Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch.Dermatol.Res. 1992;284:324-332. (Link)

Merico,F.; Bergui,L.; Gregoretti,M.G.; Ghia,P.; Aimo,G.; Lindley,I.J.; Caligaris-Cappio,F.. Cytokines involved in the progression of multiple myeloma. Clin.Exp.Immunol. 1993;92:27-31. (Link)

Seguchi,T.; Yokokawa,K.; Sugao,H.; Nakano,E.; Sonoda,T.; Okuyama,A.. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J.Urol. 1992;148:791-794. (Link)

Hirano,T.; Taga,T.; Yasukawa,K.; Nakajima,K.; Nakano,N.; Takatsuki,F.; Shimizu,M.; Murashima,A.; Tsunasawa,S.; Sakiyama,F.; .. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc.Natl.Acad.Sci.U.S.A 1987;84:228-231. (Link)